This finding not only elucidates an additional pathway contributing to p53 signaling pathway inactivation beyond TP53 gene mutation or abnormal degradation of p53 protein but also reveals the key role of non-coding RNAs in PCa progression, providing a potential therapeutic target. The gene discussed is TP53; the disease is posterior cortical atrophy.